GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today the launch of a public offering of 54,500,000 shares of its common stock held by Bayer World Investmen
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, December 1, 2020. Jeff Simmo
A new president will provide new opportunities for investors.
Elanco Animal Health Incorporated (ELAN) CEO Jeffrey Simmons on Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)
Elanco Animal Health Incorporated's (ELAN) CEO Jeff Simmons on Credit Suisse 29th Annual Virtual Healthcare Conference - Quick Version Earnings Call Transcript
Elanco Animal Health Incorporated's (ELAN) CEO Jeffrey Simmons on Q3 2020 Results - Earnings Call Transcript
Elanco Animal Health posted third-quarter earnings that edged views after completing its big Bayer Animal Health acquisition, but its sales and sales guidance lagged views. ELAN stock fell.

Elanco Animal Health: Q3 Earnings Insights

07:46am, Friday, 06'th Nov 2020
  Shares of Elanco Animal Health (NYSE:ELAN) rose 0.1% in pre-market trading after the company reported Q3 results.
GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Elura™ (capromorelin oral solution), a new prescription medication to manage weight loss in cats with
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced its first sustainability commitments, just two years after becoming an independent company. The decade
The SBPA, which has been promoting and educating paralegals since 1979, is known statewide for its innovative approach to meeting the needs of its membership.
ResearchAndMarkets.com published a new article on the AI industry

Why I Sold Elanco Animal Health

07:45am, Thursday, 10'th Sep 2020
I became an Elanco shareholder after the company acquired Aratana Therapeutics in 2019. But the high debt levels and the stagnating revenue growth for Elanco as well as Bayer's animal health business
Elanco nearly doubled from its March low through its high this past week. Unfortunately the stock's rally put it in overbought territory and it faces resistance from a downward sloped trend line.
Elanco Animal Health (NYSE:ELAN) Director John P. Bilbrey acquired 9,580 shares of Elanco Animal Health stock in a transaction on Wednesday, August 19th. The shares were bought at an average cost of $
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE